These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9062504

  • 1. Parathyroid hormone-related protein-(1-36) is biologically active when administered subcutaneously to humans.
    Henry JG, Mitnick M, Dann PR, Stewart AF.
    J Clin Endocrinol Metab; 1997 Mar; 82(3):900-6. PubMed ID: 9062504
    [Abstract] [Full Text] [Related]

  • 2. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF.
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [Abstract] [Full Text] [Related]

  • 3. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
    Plotkin H, Gundberg C, Mitnick M, Stewart AF.
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2786-91. PubMed ID: 9709948
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.
    Everhart-Caye M, Inzucchi SE, Guinness-Henry J, Mitnick MA, Stewart AF.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):199-208. PubMed ID: 8550752
    [Abstract] [Full Text] [Related]

  • 5. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
    Tørring O, Turner RT, Carter WB, Firek AF, Jacobs CA, Heath H.
    Endocrinology; 1992 Jul; 131(1):5-13. PubMed ID: 1319327
    [Abstract] [Full Text] [Related]

  • 6. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
    Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocaña A, Bisello A, Hollis BW, Rosen CJ, Wysolmerski JJ, Dann P, Gundberg C, Stewart AF.
    J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
    [Abstract] [Full Text] [Related]

  • 7. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
    Syed MA, Horwitz MJ, Tedesco MB, Garcia-Ocaña A, Wisniewski SR, Stewart AF.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.
    Fraher LJ, Klein K, Marier R, Freeman D, Hendy GN, Goltzman D, Hodsman AB.
    J Clin Endocrinol Metab; 1995 Jan; 80(1):60-4. PubMed ID: 7829640
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.
    Fraher LJ, Hodsman AB, Jonas K, Saunders D, Rose CI, Henderson JE, Hendy GN, Goltzman D.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):417-23. PubMed ID: 1322424
    [Abstract] [Full Text] [Related]

  • 10. Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: histomorphometric and biochemical investigations.
    Rosol TJ, Capen CC, Horst RL.
    J Bone Miner Res; 1988 Dec; 3(6):699-706. PubMed ID: 2855193
    [Abstract] [Full Text] [Related]

  • 11. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.
    Horwitz MJ, Tedesco MB, Sereika SM, Prebehala L, Gundberg CM, Hollis BW, Bisello A, Garcia-Ocaña A, Carneiro RM, Stewart AF.
    J Bone Miner Res; 2011 Sep; 26(9):2287-97. PubMed ID: 21544866
    [Abstract] [Full Text] [Related]

  • 12. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S, Phoojaroenchanachai M, Ploybutr S, Plengvidhya N, Peerapatdit T, Nitiyanant W, Vannasaeng S, Vichayanrat A.
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone-induced calcium release from intracellular stores in a human kidney cell line in the absence of stimulation of cyclic adenosine 3',5'-monophosphate production.
    Jobert AS, Leroy C, Butlen D, Silve C.
    Endocrinology; 1997 Dec; 138(12):5282-92. PubMed ID: 9389512
    [Abstract] [Full Text] [Related]

  • 14. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF, Cain RL, Burr DB, Jacob D, Turner CH, Hock JM.
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [Abstract] [Full Text] [Related]

  • 15. Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34.
    Blind E, Raue F, Knappe V, Schroth J, Ziegler R.
    Exp Clin Endocrinol; 1993 Aug; 101(3):150-5. PubMed ID: 8223983
    [Abstract] [Full Text] [Related]

  • 16. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
    Firek AF, Kao PC, Heath H.
    J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
    [Abstract] [Full Text] [Related]

  • 17. Decreased mRNA expression of the PTH/PTHrP receptor and type II sodium-dependent phosphate transporter in the kidney of rats fed a high phosphorus diet accompanied with a decrease in serum calcium concentration.
    Katsumata S, Masuyama R, Uehara M, Suzuki K.
    Biosci Biotechnol Biochem; 2004 Dec; 68(12):2484-9. PubMed ID: 15618618
    [Abstract] [Full Text] [Related]

  • 18. Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.
    Yaghoobian J, Morieux C, Denne MA, Bouizar Z, Ureña P, de Vernejoul MC.
    Horm Metab Res; 1998 May; 30(5):249-55. PubMed ID: 9660083
    [Abstract] [Full Text] [Related]

  • 19. Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo.
    Sato K, Fujii Y, Kasono K, Ozawa M, Imamura H, Kanaji Y, Kurosawa H, Tsushima T, Shizume K.
    Endocrinology; 1989 May; 124(5):2172-8. PubMed ID: 2539970
    [Abstract] [Full Text] [Related]

  • 20. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.